Substituted heterocyclic compounds and methods of use

   
   

The present invention relates to pyrimidine or pyridine carbamate compounds having the general Formula I: 1 and pharmaceutically acceptable salts or derivatives thereof. Also included are methods of treatment of various diseases and conditions, including inflammation, inhibition of T cell activation and proliferation, arthritis, organ transplant, ischemic or reperfusion injury, myocardial infarction, stroke, multiple sclerosis, inflammatory bowel disease, Crohn's disease, lupus, hypersensitivity, type 1 diabetes, psoriasis, dermatitis, Hashimoto's thyroiditis, Sjogren's syndrome, autoimmune hyperthyroidism, Addison's disease, autoimmune diseases, glomerulonephritis, allergic diseases, asthma, hayfever, eczema, cancer, colon carcinoma, thymoma, just to name a few, in a mammal, the methods comprising administering a therapeutically-effective amount a compound of Formula I, or a salt or derivative form thereof, as described above.

A invenção atual relaciona-se aos compostos do carbamate do pyrimidine ou do pyridine que têm a fórmula geral I: 1 e pharmaceutically sais ou derivatives aceitáveis disso. São incluídos também os métodos de tratamento de várias doenças e condições, including o inflammation, inibição da ativação da pilha de T e do ferimento do proliferation, do arthritis, do transplant do órgão, o isquêmico ou do reperfusion, infarction myocardial, curso, sclerosis múltiplo, doença inflammatory do bowel, doença de Crohn, lupus, hypersensitivity, tipo 1 diabetes, psoriasis, dermatite, thyroiditis de Hashimoto, syndrome de Sjogren, hyperthyroidism autoimmune, doença de Addison, doenças autoimmune, glomerulonephritis, doenças allergic, asthma, hayfever, eczema, cancer, carcinoma dos dois pontos, thymoma, para nomear apenas alguns, em um mamífero, os métodos que compreendem administrando uma quantidade therapeutically-eficaz um composto da fórmula I, ou um sal ou formulário derivative disso, como descrito acima.

 
Web www.patentalert.com

< Preventives and remedies for diseases in association with demyelination

< Use of (3-(2-ethylphenyl)-5-methoxyphenyl)-1H-[1,2,4]-triazole for the treatment of autoimmune diseases

> Therapeutic agents for multiple sclerosis

> Combination therapies for multiple sclerosis

~ 00173